🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

BRIEF-Valeant's former CEO may remain as consultant through 2017

Published 2016-05-31, 09:39 a/m
© Reuters.  BRIEF-Valeant's former CEO may remain as consultant through 2017
PSON
-
BHC
-

May 31 (Reuters) - Valeant Pharmaceuticals International
* Under separation agreement with former ceo pearson, he
will provide consulting services to company through december 31,
2017
* Pearson (LON:PSON) will receive $83,333 for each month during
consulting period that services are performed through end of
2016
* Pearson will receive $15,000 for each month that services
are performed for remainder of consulting period
* Former ceo pearson entitled to receive pro-rated annual
bonus in respect of 2016 fiscal year and severance payment equal
to $9 million

Source text for Eikon: ID:nEOL5fl7M9
Further company coverage: VRX.TO

(Bengaluru Newsroom: +1-646-223-8780) May 31 (Reuters) - Valeant Pharmaceuticals International Inc (NYSE:VRX)
VRX.TO
* Under separation agreement with former CEO pearson, he
will provide consulting services to company through december 31,
2017
* Pearson will receive $83,333 for each month during
consulting period that services are performed through end of
2016
* Pearson will receive $15,000 for each month that services
are performed for remainder of consulting period
* Former CEO Pearson entitled to receive pro-rated annual
bonus in respect of 2016 fiscal year and severance payment equal
to $9 million

Source text for Eikon: ID:nEOL5fl7M9
Further company coverage: VRX.TO

(Bengaluru Newsroom: +1-646-223-8780)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.